Science Update: Stem Cells and Cardiovascular Health
Let's look at some of these studies in a little more detail so you can grasp the potential benefits of supporting your body's natural release of stem cells into the bloodstream %u2026
In 2001, Vasa et al reported that compared to healthy individuals, people with cardiovascular problems had fewer endothelial progenitor cells (EPC's) in their bloodstream. EPC's are a type of stem cells responsible for the development of new blood vessels. The study also demonstrated that the EPC's isolated from people with cardiovascular problems showed less ability to migrate in tissues. The Vasa group also reported that smokers had fewer EPC's in their blood.
In 2004 Schmidt-Lucke et al measured the number of EPC's in the bloodstream of 120 individuals (43 controls and 77 individuals at risk for cardiovascular problems) and observed these individuals for ten months. At the end of this time, the authors reported that a reduced number of circulating EPC's was linked to a poor cardiovascular health prognosis.
The next year, in a similar but more extensive study, Werner et al measured the number of EPC's in the bloodstream of 19 individuals, and observed these individuals for one year. Overall, the people with more circulating EPC's experienced fewer cardiovascular problems and, conversely, the people who had fewer EPC's in their blood showed increased incidences of cardiovascular events.
Thanks to recent studies, scientists now understand why greater numbers of stem cells in the bloodstream equate to better cardiovascular health. In essence, when a tissue has poor blood circulation, it lacks oxygen. And when a tissue lacks oxygen, it releases compounds that accomplish two specific tasks: 1) attraction of EPC's into the tissue, and 2) conversion of EPC's into capillary cells. Therefore, whenever a tissue is lacking oxygen, a process is triggered whereby circulating stem cells migrate to the tissue and contribute to the development of new capillaries. This leads to greater delivery of oxygen and nutrients, thereby helping the tissue maintain better health.
When we understand that poor oxygen and insufficient nutrient delivery to organs and tissues are two of the most common underlying causes for a wide variety of health problems, it is clear that increasing the number of circulating stem cells becomes one of the most valuable strategies for maintaining optimal health.
Disclaimer: This article is for educational purposes only and does not constitute medical advice. The opinions expressed herein are those of the author and any products mentioned, while supported by science, are not intended to diagnose, mitigate or treat any disease or illness.
For information on supporting your body's natural ability to release stem cells, and to take advantage of financial opportunities in this exciting arena, visit: http://tinyurl.com/c7bldc
PEOPLE HELPING PEOPLE
The Story of STEMTech
STEMTech HealthSciences was founded in 2005 in order to bring a new breakthrough product technology to the marketplace. The beginnings of this natural, phytoceutical dietary supplement started as a conceptual theory in the mind of a research scientist at the turn of the century.
Prior to theory development, this scientist, Christian Drapeau, accumulated many years of experience observing the apparent health benefits derived from a remarkable fresh water plant. These beneficial results intrigued this young neurophysiologist, and he began intensive research to examine this phenomenon.
Initial results of this research lead him and his colleague, Dr. Gitte Jensen, to hypothesize what appeared to be a very intriguing theory involving adult stem cells, and how isolated extracts of this aqua-botanical, seemed to work to optimize the natural behavior of stem cells in the body.
In 2000, the two scientists shared their views with Howard Newman, the owner of Desert Lake Technologies (DLT). DLT is a company with vast experience in aquaculture and harvesting of this aqua-botanical raw material. Together, this team ventured forward with the vision, skill and courage required to undertake a radical, new way of thinking about how the body keeps itself healthy. Using science to unlock the secrets in nature, the theory began to take on a life of its own.
In 2002, the theory was published in a medical journal named Medical Hypotheses, while other scientists from around the world also continued to publish research that further strengthened what Drapeau and Jensen believed they had discovered.
In 2004, a U.S. patent was awarded to these inventors, and further internal and external studies continued to corroborate their position. Desert Lake Technologies was now ready to transition from research & development, and bring the concept and the product to market in 2005.
The company then turned to a top industry professional, an MBA with a 17 year track record of success, to help guide them in the strategic planning process. After many months of analysis, Ray Carter recommended, and the team decided to form STEMTech HealthSciences, in order to launch the product through the power of the network marketing industry. Mr. Carter accepted the company's request for him to organize and run the new company, as they targeted a market pre-launch in the fall of 2005.
The name of this product is StemEnhance®, and it is a breakthrough, natural botanical extract that supports wellness, by helping your body maintain healthy stem cell physiology. It is the very first product on the market from the latest phytoceutical product category called "stem cell enhancers".
When you take two capsules of StemEnhance, the ingredients help to support the release of stem cells from the bone marrow into the bloodstream. Through a natural process, those stem cells then travel to areas of the body where they are most needed.
Recognizing that the novelty of this breakthrough product will require a great deal of consumer education, STEMTech has put together a media campaign strategy in order to educate and create the awareness we desire, to give StemEnhance the brand name recognition that will assist all of our independent distributors to more successfully market the product, while generating countless leads.
StemEnhance is only available through STEMTech HealthSciences, Inc. and its independent distributors. The formulation is patented and is the first of its kind on the market. So whether you are a "baby boomer", athlete, or anyone else looking to optimize health, StemEnhance is for you.
Fetching RSS feed... please stand byThe latest from Google about this
- Commentarius de Prognosticis: Adult Stem Cell Research Gets a ...
- At the outset, studies focused on embryonic stem cells, because it was believed that only these had significant capabilities of multiplication and differentiation. Numerous studies, however, show that adult stem cells also have a ...
- Sorting Through Challenges, Opportunities Of Stem Cells - Venture ...
- Margolin: Embryonic stem cells are a very interesting field, but it's still a very early stage. But with adult stem cells, we expect several products to come in to the market soon, including Gamida. So with adult stem cells, ...
- <em>Is Anybody There?</em>: Add Another 1 to the Adult Stem Cell ...
- Add Another 1 to the Adult Stem Cell Column, Embryonic Stem cells Still at Zero. & we are not talking about something down the road in 5 or 10 years. As you will note in the last paragraph, this could very well be approved as a NHS ...
- H Panji Irawan: Stem Cells for Heart Muscle Cells
- MARVEL: This Phase II/III trial will assess safety and efficacy of MyoCell (Bioheart) autologous clinical cell therapy into myocardium post myocardial infarction to determine if adult stem cells can improve heart function. ...
